US OptionsDetailed Quotes

GSK240802P39500

Watchlist

0.08
-0.32-80.00%

15min DelayClose Aug 2 15:58 ET

0.10High0.07Low

GlaxoSmithKline Stock Discussion

Options Newsman

Jul 29 20:07

Columns Options Market Statistics: Paypal Q2 Earnings to Reflect Competitive Landscape, Options Pop

News Highlights
$NVIDIA(NVDA.US)$ stock fell 1.30%. Its options trading volume was 2.62 million. Call contracts account for 61.5% of the total trading volume.
$Pfizer(PFE.US)$ stock fell 0.16%. Its options trading volume was 0.30 million. Call contracts account for 57.8% of the total trading volume.The $24 calls expiring August 16 were traded most actively.
Pfizer, $GlaxoSmithKline(GSK.US)$, and $Moderna(MRNA.US)$ are in a ...

103208831

Jul 10 07:08

$GlaxoSmithKline(GSK.US)$ Very poor performance stock. Not suprise in the end of 2024, it will be worth around $25

Arrayfunction

Jul 8 20:32

Can anyone clue me in on what's contributed to the recent poor performance?

I am quite stumped about $GlaxoSmithKline(GSK.US)$ in the past few weeks. It has had fairly steady long-term growth in the past few years and there doesn't seem to be that much worrying news recently. Is it just going through an oscillation at the moment?

Mr Value investor

Jul 2 09:43

$GlaxoSmithKline(GSK.US)$ is this going for 52 week low? or a buy now?

Sanjeev Kaushik

Jun 14 06:41

Magnificent Seven vs. the Granolas

The term 'GRANOLAS' was coined by Goldman Sachs in 2020 based on a loose acronym of the stocks' names. It includes GlaxoSmithKline, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L'Oréal, LVMH, AstraZeneca, SAP and Sanofi.

Meltyy

Jun 11 03:48

🔔 FDA PDUFA Update…

🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals(REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb(BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline(GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...

Meltyy

Jun 7 03:39

🚨 June PDUFAs

» 15+ upcoming FDA decisions to watch: 👀 👇
$GlaxoSmithKline(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$Eli Lilly and Co(LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals(REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron(GERN.US)$ : Imetelstat
$Merck & Co(MRK.US)$ : V116
$Amgen(AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics(SRPT.US)$ : ELEVIDYS
$Merck & Co(MRK.US)$ : KEYTRUDA ...

guest007843391

Jun 6 09:12

$GlaxoSmithKline(GSK.US)$ do you guys think the fda case will be approved tomorrow? the company has had positive clinical trials.

Meltyy

May 24 03:20

See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb(BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals(REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US)$ : Augtyro...

Shaaaw

May 5 22:10

Top 10 drug companies raked in NEARLY TRIPLE the revenue in 2023 ($491B) vs 2013 ($165B) 2013 vs. 2023.
$AbbVie(ABBV.US)$ +189%
$Bristol-Myers Squibb(BMY.US)$ +175%
$Johnson & Johnson(JNJ.US)$ +95%
$AstraZeneca(AZN.US)$ +78%
$NVM +45%
$Merck & Co(MRK.US)$ +37%
$ROCHE HOLDING AG(RHHBY.US)$ +27%
$Pfizer(PFE.US)$ +13%
$GlaxoSmithKline(GSK.US)$ +13%
----- $SPDR S&P 500 ETF(SPY.US)$ +12% -----
$Sanofi(SNY.US)$ +3%
Source: Arjun Murthy on the HR app!

No comment yet